New hope for kids with severe skin condition
NCT ID NCT04123795
Summary
This study is testing a medication called certolizumab pegol in children and teenagers aged 6 to 17 who have moderate to severe plaque psoriasis. The main goals are to understand how the drug behaves in young bodies and to check its safety. It is a Phase 3 trial, which means researchers are gathering more evidence about how well it works and its side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ps0007 50156
Arlington, Texas, 76011, United States
-
Ps0007 50161
Los Angeles, California, 90045, United States
-
Ps0007 50162
Fountain Valley, California, 92708, United States
-
Ps0007 50168
Chicago, Illinois, 60611, United States
-
Ps0007 50169
Jacksonville, Florida, 32256, United States
-
Ps0007 50175
Phoenix, Arizona, 85006, United States
-
Ps0007 50183
Calgary, Canada
-
Ps0007 50187
Edmonton, Canada
-
Ps0007 50196
Thousand Oaks, California, 91320, United States
-
Ps0007 50217
Boca Raton, Florida, 33428, United States
-
Ps0007 50225
Calgary, Canada
-
Ps0007 50230
Rome, Georgia, 30161, United States
-
Ps0007 50232
Detroit, Michigan, 48202, United States
-
Ps0007 50248
Hialeah, Florida, 33016, United States
-
Ps0007 50265
San Juan, Puerto Rico
-
Ps0007 50268
Miami, Florida, 33155, United States
-
Ps0007 50269
Wellington, Florida, 33449, United States
-
Ps0007 50277
San Antonio, Texas, 78218, United States
-
Ps0007 50286
Topeka, Kansas, 66614, United States
Conditions
Explore the condition pages connected to this study.